Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Drug Delivery

Sigmoid Pharma agrees to acquire Freund Pharmatec Sigmoid Pharma has entered into an agreement to acquire Freund Pharmatec.
Drug Research > Drug Delivery > News
ViaCyte acquires rights to BetaLogics assets from Janssen ViaCyte and Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, have agreed to consolidate the assets of the Janssen BetaLogics group into ViaCyte.
Drug Research > Drug Delivery > News Eagle Pharmaceuticals wins FDA fast track designation for Ryanodex to treat exertional heat stroke The US Food and Drug Administration (FDA) has granted Fast Track designation to Eagle Pharmaceuticals' RYANODEX (dantrolene sodium for injectable suspension) for the treatment of exertional heat stroke (EHS), an investigational new indication for the product.
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight

View all Drug Delivery news or find news targeted to your interests
Eagle Pharmaceuticals wins FDA fast track designation for Ryanodex to treat exertional heat stroke
The US Food and Drug Administration (FDA) has granted Fast Track designation to Eagle Pharmaceuticals' RYANODEX (dantrolene sodium for injectable suspension) for the treatment of exertional heat stroke (EHS), an investigational new indication for the product.
Drug Research > Drug Delivery > News
Galapagos’ experimental bowel drug fails to meet end point in phase 2a study
By PBR Staff Writer
Galapagos's experimental bowel disease treatment, dubbed GLPG1205, has failed to meet the end point in a phase 2a study.
Drug Research > Drug Delivery > News
Ixchelsis achieves positive clinical POC for IX-01 to treat premature ejaculation
By PBR Staff Writer
UK biotechnology firm Ixchelsis has achieved positive clinical proof of concept (POC) for IX-01, its oral oxytocin receptor antagonist being developed to treat premature ejaculation (PE).
Drug Research > Drug Delivery > News
vasopharm raises EUR20m to advance treatment for traumatic brain injury
vasopharm, a privately held biopharmaceutical company focusing on novel therapeutics for the treatment of cerebrovascular diseases, has raised EUR20m of new capital.
Drug Research > Drug Delivery > News
GlobalData says pulmonary arterial hypertension therapy market will hit $4.75bn by 2024
The Pulmonary Arterial Hypertension (PAH) therapeutics market will experience modest growth from $3.45bn in 2014 to $4.75bn by 2024, representing a Compound Annual Growth Rate (CAGR) of 3.2%, according to research and consulting firm GlobalData.
Drug Research > Drug Delivery > News
Novartis launches Entresto heart failure drug in UK
By PBR Staff Writer
Novartis has launched its Entresto (sacubitril/valsartan) heart failure drug in the UK.
Drug Research > Drug Delivery > News
Graham Boulnois appointed as chairman of Medicines Technologies Catapult
Life sciences businessman and academic Professor Graham Boulnois has been appointed as chairman of the Medicines Technologies Catapult.
Drug Research > Drug Delivery > News
Patient dies in phase 1 clinical trial of Bial's drug in France
By PBR Staff Writer
One patient has been declared brain dead in Bial's phase I drug trial at the University Hospital of Rennes in France.
Drug Research > Drug Delivery > News
Syros Pharmaceuticals closes $40m financing of preferred stock
Syros Pharmaceuticals has closed a $40m financing of preferred stock.
Drug Research > Drug Delivery > News
Zymeworks makes equity investment in Kairos Therapeutics
Zymeworks has made an undisclosed equity investment in Kairos Therapeutics, which specializes in the discovery and development of antibody drug conjugates (ADCs) and is a spin-out of The Centre for Drug Research and Development (CDRD).
Drug Research > Drug Delivery > News
View all Drug Delivery news or find news targeted to your interests